In vitro Percutaneous Absorption of 14C-Labeled β-Lactone Promises Topical Delivery of New Bacterial Virulence Inhibitors

ChemMedChem

Volumn 7, Issue 8, 2012, Pages 1490-1495

  Lorenz Baath, Katrin ^b   Korotkov, Vadim S ^b   LiersevonGostomski, Christoph ^c   Sieber, Stephan A ^a  

^a Munich Center for Integrated Protein Science   (Germany)

^b EXIST Transfer of Research   (Germany)

^c Radiochemie München ^*  (Germany)

Author keywords

Anti infectives; Drug delivery; Isotopic labeling; Lactones; Radioactivity

Indexed keywords

BETA LACTONE; CARBON 14; COSMETIC; LACTONE DERIVATIVE; PETROLATUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENCY; DRUG STABILITY; DRUG SYNTHESIS; EPIDERMIS; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SKIN; SKIN ABSORPTION; SKIN PERMEABILITY; STRATUM CORNEUM; SWINE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; CARBON RADIOISOTOPES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; LACTONES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PETROLATUM; SKIN; SKIN ABSORPTION; SWINE; VIRULENCE;

EID: 84864401314     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201200229     Document Type: Article

References (23)

1. H. F. Chambers, F. R. Deleo, Nat. Rev. Microbiol. 2009, 7, 629-641.
2. S. Y. Tong, L. F. Chen, V. G. Fowler, Jr., Semin. Immunopathol. 2012, 34, 185-200.
3. M. E. Jones, J. A. Karlowsky, D. C. Draghi, C. Thornsberry, D. F. Sahm, D. Nathwani, Int. J. Antimicrob. Agents 2003, 22, 406-419.
4. R. S. Daum, N. Engl. J. Med. 2007, 357, 380-390;
5. L. Tognetti, C. Martinelli, S. Berti, J. Hercogova, T. Lotti, F. Leoncini, S. Moretti, J. Eur. Acad. Dermatol. Venereol. 2012, DOI:
6. H. K. Kim, V. Thammavongsa, O. Schneewind, D. Missiakas, Curr. Opin. Microbiol. 2012, 15, 92-99.
7. L. L. Han, L. K. McDougal, R. J. Gorwitz, K. H. Mayer, J. B. Patel, J. M. Sennott, J. L. Fontana, J. Clin. Microbiol. 2007, 45, 1350-1352;
8. B. A. Diep, S. R. Gill, R. F. Chang, T. H. Phan, J. H. Chen, M. G. Davidson, F. Lin, J. Lin, H. A. Carleton, E. F. Mongodin, G. F. Sensabaugh, F. Perdreau-Remington, Lancet 2006, 367, 731-739.
9. N. E. Scangarella-Oman, R. M. Shawar, S. Bouchillon, D. Hoban, Expert Rev. Anti-Infect. Ther. 2009, 7, 269-279.
10. R. J. Gordon, F. D. Lowy, Clin. Infect. Dis. 2008, 46, S350-359.
11. D. Frees, S. N. Qazi, P. J. Hill, H. Ingmer, Mol. Microbiol. 2003, 48, 1565-1578;
12. D. Frees, K. Sorensen, H. Ingmer, Infect. Immun. 2005, 73, 8100-8108;
13. A. Michel, F. Agerer, C. R. Hauck, M. Herrmann, J. Ullrich, J. Hacker, K. Ohlsen, J. Bacteriol. 2006, 188, 5783-5796.
14. T. Böttcher, S. A. Sieber, J. Am. Chem. Soc. 2008, 130, 14400-14401;
15. T. Böttcher, S. A. Sieber, ChemBioChem 2009, 10, 663-666.
16. T. J. Franz, P. A. Lehman, S. G. Raney, Skin Pharmacol. Physiol. 2009, 22, 276-286.
17. E. Zeiler, V. S. Korotkov, K. Lorenz-Baath, T. Böttcher, S. A. Sieber, Bioorg. Med. Chem. 2012, 20, 583-591.
18. S. W. Cho, D. Romo, Org. Lett. 2007, 9, 1537-1540.
19. H. Trommer, R. H. Neubert, Skin Pharmacol. Physiol. 2006, 19, 106-121.
20. C. L. Simpson, D. M. Patel, K. J. Green, Nat. Rev. Mol. Cell Biol. 2011, 12, 565-580.
21. T. J. Franz, J. Invest. Dermatol. 1975, 64, 190-195;
22. OECD, Test No. 428: Skin Absorption: InVitro Method, OECD Guidelines for the Testing of Chemicals, Section4, OECD Publishing, 2004, DOI:
23. R. L. Bronaugh, R. F. Stewart, J. Pharm. Sci. 1984, 73, 1255-1258.